Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i (ACHIEVE-SGLT2i) Registry

NCT06932081 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06932081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06932081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i (ACHIEVE-SGLT2i) Registry
Lead sponsor
Leiden University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
December 31, 2027
Enrollment
400 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

adult congenital heart disease, congenital heart disease, congenitally corrected transposition of the great arteries, fontan, single ventricle, systemic right ventricle, tetralogy of fallot (tof), transposition of the great arteries